Patent · US Active

Pyrazolyl quinoxaline kinase inhibitors

US10519137B2 · kind B2 · utility

5Cited by

34References

18Claims

0Family size

Assignee

ASTEX THERAPEUTICS LIMITED · GB

Inventors

Gordon Saxty · Cambridge, GB
Christopher William Murray · Cambridge, GB
Valerio Berdini · Cambridge, GB
Gilbert Ebai Besong · Bad Dürkheim, DE
Steven John Woodhead · San Diego, US
Michael Reader · Bishop's Stortford, GB
Laurence Anne Mevellec · Louviers, FR
Patrick René Angibaud · Louviers, FR
Eddy Jean Edgard Freyne · Rumst, BE
Timothy Pietro Suren Perera · Felton, GB
Berthold Wroblowski · Vosselaar, BE
Alexandra Papanikos · Ekeren, BE
Olivier Alexis Georges Querolle · Évreux, FR
Isabelle Noëlle Constance Pilatte · Louviers, FR
Pascal Bonnet · Olivet, FR
Werner Constant Johan Embrechts · Beerse, BE
Rhalid Akkari · Pantin, FR
Lieven Meerpoel · Beerse, BE

Key dates

Filing date	Nov 13, 2017
Grant date	Dec 31, 2019
Priority date	—
Expiry date	Nov 13, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07F9/6524
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to new quinoxaline derivative compounds, to pharmaceutical compositions comprising said compounds, to processes for the preparation of said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.